rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ABVX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ABIVAX at Guggenheim conference: obefazimod data lift outlook
      Nov 10Investing.comABVX
      10 Health Care Stocks Whale Activity In Today’s Session
      Oct 23BenzingaABVXTVTX
      Arquitos Capital Q2 2026 Investor Letter

      Arquitos returned 64.8% net in Q2 2026 driven by strong performance in Liquidia and Abivax. Read the full letter for more details.

      Oct 22Seeking AlphaABVXLQDA
      Piper Sandler reiterates Abivax stock rating on trial data
      Oct 21Investing.comABVX
      Abivax (ABVX): Cleared Safety Overhang and Phase 3 Data De-Risk Path to Commercialization
      Oct 7Yahoo FinanceABVX
      ABIVAX Société Anonyme (ENXTPA:ABVX) Just Gave Investors Something To Think About

      ABIVAX Société Anonyme (ENXTPA:ABVX) has just paired deeper operating cash use and wider losses with fresh leadership hires and extended funding, creating a complex backdrop for anyone tracking the stock today. Recent moves have come against a tougher tape for ABIVAX Société Anonyme, with the share price down 28.78% year to date and 15.91% over 30 days, even as the 1 year total shareholder return of 16.50% and the very large 3 year total shareholder return of 446.00% point to longer term...

      Sep 27Yahoo FinanceABVX
      ABIVAX Société Anonyme (ENXTPA:ABVX) Appoints New Chief Medical And Technical Officers

      ABIVAX Société Anonyme (ENXTPA:ABVX) has appointed a new Chief Medical Officer and a new Chief Technical Officer. The fresh leadership roles are focused on medical strategy, product development and technical operations across Abivax SA's pipeline. The appointments are intended to support the firm's efforts around clinical programs and preparation for potential commercialization activities. The appointment of a new Chief Medical Officer and Chief Technical Officer should not be the only...

      Sep 26Yahoo FinanceABVX
      ABIVAX (ABVX) Uses More Cash. Can its Funding Cover a Potential Launch?
      Sep 26Yahoo FinanceABVX
      Abivax: Priced Right Ahead Of 2 Make-Or-Break Catalysts (NASDAQ:ABVX)

      Abivax is advancing obefazimod for ulcerative colitis and Crohn’s, with recent safety concerns now largely addressed. Read more on ABVX stock here.

      Sep 23Seeking AlphaABVX
      These Analysts Slash Their Forecasts On Abivax Following H1 Results - Abivax (NASDAQ:ABVX)

      Abivax missed EPS estimates but beat sales in H1; shares dipped. Wedbush and Truist cut price targets to $118 and $151.

      Sep 22BenzingaABVX
      Wedbush Cuts Price Target on Abivax to $118 From $160, Keeps Neutral Rating

      Abivax (ABVX) has an average rating of buy and mean price target of $164.20, according to analysts p

      Sep 22Yahoo FinanceABVX
      Abivax Says Chris Rabbat to Succeed Fabio Cataldi as Chief Medical Officer

      Abivax (ABVX) said Monday Fabio Cataldi will be leaving the company in the fourth quarter of 2026, a

      Sep 21Yahoo FinanceABVX
      Earnings Scheduled For September 21, 2026 - Ennis (NYSE:EBF), Abivax (NASDAQ:ABVX)

      Companies Reporting Before The Bell • Ennis (NYSE:EBF) is expected to report earnings for its second quarter. Companies Reporting After The Bell • Abivax (NASDAQ:ABVX) is projected to report quarterly loss at $1.08 per

      Sep 21BenzingaABVX
      Abivax Presents Business Updates and First Half 2026 Financial Results
      Sep 21MorningstarABVX
      Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
      Sep 14BenzingaABVX
      Earnings To Watch: Abivax SA (XPAR:ABVX) Reports Q2 2026 Result

      At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

      Sep 11Yahoo FinanceABVX
      Goldman Sachs initiates Abivax stock coverage with buy rating
      Sep 10Investing.comABVX
      Why is Abivax stock climbing today?
      Sep 10Investing.comABVX
      Goldman Sachs Initiates Coverage on Abivax With Buy Rating, $155 Price Target

      Abivax (ABVX) has an average rating of buy and mean price target of $162.06, according to analysts p

      Sep 10Yahoo FinanceABVX
      Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why

      Abivax SA Sponsored ADR (ABVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

      Sep 8Yahoo FinanceABVX
      Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

      Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis...

      Aug 28BarchartABVX

      This is the newest page. Registered accounts read further back.